A Study to Investigate the Pharmacokinetic Profile of ALXN2050 Modified Release Prototype Formulations and Immediate Release Reference Tablet in Healthy Adult Participants
Clinical trial NCT05780645 · COMPLETED
Trial details
- NCT number
- NCT05780645
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2024-02-26
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.